AZTA

Azenta, Inc.

A life sciences company that helps researchers around the world store, manage, and analyze biological samples. Its automated ultra-cold freezers, sample tubes and vials, lab software, and cold-chain logistics keep everything from clinical-trial specimens to blood samples safe, while its GENEWIZ brand provides gene sequencing and DNA synthesis services. Founded in 1978 in Massachusetts as Brooks Automation, it spent decades building robots for making semiconductors before pivoting to biological samples and renaming itself Azenta in late 2021. Fittingly, the same robotics know-how that once handled delicate silicon wafers now gently shuffles frozen vials in automated freezers—an unexpected turn from chips to cells.

CUSIP: 114340102HealthcareUS1 holder

Ownership Activity Financials Filings

Insiders

Ranked by how much each holding moved in the last year

Insider

Koffey QuentinDirector · 1 transaction

4.62M—

Granted 5.7K

Marotta JohnPresident and CEO, Director · 3 transactions

213.2K+98.7%

Granted 118.2K · Sold 316

Lin Lawrence Y.EVP, CFO and Treasurer · 2 transactions

79.7K+83.1%

Granted 36.7K

Starr EphraimSVP, Gen Counsel & Secretary · 2 transactions

68.4K+81%

Granted 34.2K

Cornog William LDirector · 1 transaction

45.5K+12.2%

Bought 10.0K

Zhou GingerSVP and GM, Multiomics · 2 transactions

38.8K+44.4%

Granted 13.0K

Pirogova OlgaSVP and CHRO · 2 transactions

33.0K+80.7%

Granted 16.3K

McLaughlin EricaDirector · 1 transaction

22.5K+33.6%

Granted 5.7K

Casal FrankDirector · 1 transaction

21.8K+49.7%

Granted 7.2K

Martin William E. IIIPresident Multiomics · 1 transaction

17.8K—

Granted 17.8K

Nova Tina SusanDirector · 1 transaction

15.8K+56%

Granted 5.7K

Doshi DipalDirector · 1 transaction

9.7K+140.2%

Granted 5.7K

Insider	Stake change	Holds now	Granted / vested	Bought	Sold
Koffey QuentinDirector · 1 transaction	—	4.62M	5.7K	—	—
Marotta JohnPresident and CEO, Director · 3 transactions	+98.7%	213.2K	118.2K	—	316
Lin Lawrence Y.EVP, CFO and Treasurer · 2 transactions	+83.1%	79.7K	36.7K	—	—
Starr EphraimSVP, Gen Counsel & Secretary · 2 transactions	+81%	68.4K	34.2K	—	—
Cornog William LDirector · 1 transaction	+12.2%	45.5K	—	10.0K	—
Zhou GingerSVP and GM, Multiomics · 2 transactions	+44.4%	38.8K	13.0K	—	—
Pirogova OlgaSVP and CHRO · 2 transactions	+80.7%	33.0K	16.3K	—	—
McLaughlin EricaDirector · 1 transaction	+33.6%	22.5K	5.7K	—	—
Casal FrankDirector · 1 transaction	+49.7%	21.8K	7.2K	—	—
Martin William E. IIIPresident Multiomics · 1 transaction	—	17.8K	17.8K	—	—
Nova Tina SusanDirector · 1 transaction	+56%	15.8K	5.7K	—	—
Doshi DipalDirector · 1 transaction	+140.2%	9.7K	5.7K	—	—

Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.